Stents: Biomechanics, Biomaterials, and Insights from Computational Modeling

Coronary stents have revolutionized the treatment of coronary artery disease. Improvement in clinical outcomes requires detailed evaluation of the performance of stent biomechanics and the effectiveness as well as safety of biomaterials aiming at optimization of endovascular devices. Stents need to harmonize the hemodynamic environment and promote beneficial vessel healing processes with decreased thrombogenicity. Stent design variables and expansion properties are critical for vessel scaffolding. Drug-elution from stents, can help inhibit in-stent restenosis, but adds further complexity as drug release kinetics and coating formulations can dominate tissue responses. Biodegradable and bioabsorbable stents go one step further providing complete absorption over time governed by corrosion and erosion mechanisms. The advances in computing power and computational methods have enabled the application of numerical simulations and the in silico evaluation of the performance of stent devices made up of complex alloys and bioerodible materials in a range of dimensions and designs and with the capacity to retain and elute bioactive agents. This review presents the current knowledge on stent biomechanics, stent fatigue as well as drug release and mechanisms governing biodegradability focusing on the insights from computational modeling approaches.

[1]  Claudio Chiastra,et al.  Patient-specific simulations of stenting procedures in coronary bifurcations: two clinical cases. , 2013, Medical engineering & physics.

[2]  G. Stefanini,et al.  Coronary Stents: The Impact of Technological Advances on Clinical Outcomes , 2015, Annals of Biomedical Engineering.

[3]  S. Leen,et al.  Micro-scale testing and micromechanical modelling for high cycle fatigue of CoCr stent material. , 2015, Journal of the mechanical behavior of biomedical materials.

[4]  S. Hossainy,et al.  Modeling of degradation and drug release from a biodegradable stent coating. , 2007, Journal of biomedical materials research. Part A.

[5]  P. Serruys,et al.  Progress in treatment by percutaneous coronary intervention: the stent of the future. , 2013, Revista espanola de cardiologia.

[6]  Michail I. Papafaklis,et al.  In vivo assessment of the three-dimensional haemodynamic micro-environment following drug-eluting bioresorbable vascular scaffold implantation in a human coronary artery: fusion of frequency domain optical coherence tomography and angiography. , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[7]  Claire Conway,et al.  Computer Simulation of the Mechanical Behaviour of Implanted Biodegradable Stents in a Remodelling Artery , 2016 .

[8]  Gregg W Stone,et al.  One-Year Clinical Results With the Slow-Release, Polymer-Based, Paclitaxel-Eluting TAXUS Stent: The TAXUS-IV Trial , 2004, Circulation.

[9]  E. Edelman,et al.  Low background, pulsatile, in vitro flow circuit for modeling coronary implant thrombosis. , 2002, Journal of biomechanical engineering.

[10]  K. Himmelstein,et al.  A simultaneous transport-reaction model for controlled drug delivery from catalyzed bioerodible polymer matrices , 1985 .

[11]  Raimund Erbel,et al.  Drug-eluting bioabsorbable magnesium stent. , 2004, Journal of interventional cardiology.

[12]  S. W. Robertson,et al.  Fatigue and durability of Nitinol stents. , 2008, Journal of the mechanical behavior of biomedical materials.

[13]  Claudio Chiastra,et al.  Biomechanical Modeling to Improve Coronary Artery Bifurcation Stenting: Expert Review Document on Techniques and Clinical Implementation. , 2015, JACC. Cardiovascular interventions.

[14]  R. Virmani,et al.  Pathological Correlates of Late Drug-Eluting Stent Thrombosis: Strut Coverage as a Marker of Endothelialization , 2007, Circulation.

[15]  Ivan Napoleão Bastos,et al.  A simple model for slow strain rate and constant load corrosion tests of austenitic stainless steel in acid aqueous solution containing sodium chloride , 2008 .

[16]  Sean B. Leen,et al.  Micromechanical methodology for fatigue in cardiovascular stents , 2012 .

[17]  Sean McGinty,et al.  A decade of modelling drug release from arterial stents. , 2014, Mathematical biosciences.

[18]  J. Son,et al.  Clinical outcomes between different stent designs with the same polymer and drug: comparison between the Taxus Express and Taxus Liberte stents , 2012, The Korean journal of internal medicine.

[19]  E. Edelman,et al.  Specific binding to intracellular proteins determines arterial transport properties for rapamycin and paclitaxel. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Stéphane Chapuliot,et al.  A comparison of lifetime prediction methods for a thermal fatigue experiment , 2006 .

[21]  M. Peuster,et al.  A novel approach to temporary stenting: degradable cardiovascular stents produced from corrodible metal—results 6–18 months after implantation into New Zealand white rabbits , 2001, Heart.

[22]  M. Le May,et al.  Does stent strut design impact clinical outcomes: comparative safety and efficacy of Endeavor Resolute versus Resolute Integrity zotarolimus-eluting stents. , 2015, Clinical and investigative medicine. Medecine clinique et experimentale.

[23]  Michael Joner,et al.  Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. , 2006, Journal of the American College of Cardiology.

[24]  Daniel S. Levi,et al.  Materials and Manufacturing Technologies Available for Production of a Pediatric Bioabsorbable Stent , 2013, BioMed research international.

[25]  Elazer R Edelman,et al.  Stent elution rate determines drug deposition and receptor-mediated effects. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[26]  Neil W. Bressloff,et al.  Design Optimisation of Coronary Artery Stent Systems , 2015, Annals of Biomedical Engineering.

[27]  John Cater,et al.  Hemodynamics in Idealized Stented Coronary Arteries: Important Stent Design Considerations , 2015, Annals of Biomedical Engineering.

[28]  R M Nerem,et al.  Regulation of endothelial cell nitric oxide synthase mRNA expression by shear stress. , 1995, The American journal of physiology.

[29]  S. Bölükbas,et al.  Drug-eluting Stents , 2009, Der Chirurg.

[30]  P. Uggowitzer,et al.  Design strategy for biodegradable Fe-based alloys for medical applications. , 2010, Acta biomaterialia.

[31]  Timothy J. Gundert,et al.  Local hemodynamic changes caused by main branch stent implantation and subsequent virtual side branch balloon angioplasty in a representative coronary bifurcation. , 2010, Journal of applied physiology.

[32]  A. Tzafriri,et al.  Luminal flow patterns dictate arterial drug deposition in stent-based delivery. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[33]  P. Teirstein,et al.  Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease. , 2015, The New England journal of medicine.

[34]  Shiwei Zhou,et al.  Mathematical modeling of degradation for bulk-erosive polymers: applications in tissue engineering scaffolds and drug delivery systems. , 2011, Acta biomaterialia.

[35]  R. Virmani,et al.  Comparison of Inflammatory Response After Implantation of Sirolimus- and Paclitaxel-Eluting Stents in Porcine Coronary Arteries , 2009, Circulation.

[36]  Neville Kukreja,et al.  Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study , 2007, The Lancet.

[37]  Adel A. Abdel-Wahab,et al.  Dynamic simulation of stent deployment - effects of design, material and coating , 2013 .

[38]  P. Fitzgerald,et al.  Drug delivery via nano-, micro and macroporous coronary stent surfaces , 2007, Expert opinion on drug delivery.

[39]  Y. Levy,et al.  Evaluation of drug-eluting stents' coating durability--clinical and regulatory implications. , 2009, Journal of biomedical materials research. Part B, Applied biomaterials.

[40]  J. A. Grogan,et al.  Optimizing the design of a bioabsorbable metal stent using computer simulation methods. , 2013, Biomaterials.

[41]  Gerhard A Holzapfel,et al.  Changes in the mechanical environment of stenotic arteries during interaction with stents: computational assessment of parametric stent designs. , 2005, Journal of biomechanical engineering.

[42]  Danika M. Hayman,et al.  An Overview of Mechanical Properties and Material Modeling of Polylactide (PLA) for Medical Applications , 2015, Annals of Biomedical Engineering.

[43]  Junaid Zafar,et al.  Medical Stents : State of the Art and Future Directions Coronary Stent Materials and Coatings : A Technology and Performance Update , 2015 .

[44]  Michael R Moreno,et al.  Effects of stent design parameters on normal artery wall mechanics. , 2006, Journal of biomechanical engineering.

[45]  E. Edelman,et al.  Stent Thrombogenicity Early in High-Risk Interventional Settings Is Driven by Stent Design and Deployment and Protected by Polymer-Drug Coatings , 2011, Circulation.

[46]  Edward Parsonage,et al.  A dissolution-diffusion model for the TAXUS drug-eluting stent with surface burst estimated from continuum percolation. , 2008, Journal of biomedical materials research. Part B, Applied biomaterials.

[47]  Giuseppe Musumeci,et al.  Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting Stent: Should We Be Cautious? , 2004, Circulation.

[48]  Sanjay Pant,et al.  The Influence of Strut-Connectors in Stented Vessels: A Comparison of Pulsatile Flow Through Five Coronary Stents , 2010, Annals of Biomedical Engineering.

[49]  Sanjay Pant,et al.  Multiobjective design optimisation of coronary stents. , 2011, Biomaterials.

[50]  Joel L. Berry,et al.  Experimental and Computational Flow Evaluation of Coronary Stents , 2000, Annals of Biomedical Engineering.

[51]  F. Cardarelli Less Common Nonferrous Metals , 2000 .

[52]  A. Tzafriri,et al.  Lesion complexity determines arterial drug distribution after local drug delivery. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[53]  Hao-Ming Hsiao,et al.  An intriguing design concept to enhance the pulsatile fatigue life of self-expanding stents , 2013, Biomedical Microdevices.

[54]  D. Mantovani,et al.  Degradable metallic biomaterials: design and development of Fe-Mn alloys for stents. , 2009, Journal of biomedical materials research. Part A.

[55]  S. McKee,et al.  Some design considerations for polymer-free drug-eluting stents: a mathematical approach. , 2015, Acta biomaterialia.

[56]  Wei Wu,et al.  Finite Element Shape Optimization for Biodegradable Magnesium Alloy Stents , 2010, Annals of Biomedical Engineering.

[57]  P. McHugh,et al.  Computational Investigation of the Delamination of Polymer Coatings During Stent Deployment , 2010, Annals of Biomedical Engineering.

[58]  Tom Duerig,et al.  Self-expanding nitinol stents: material and design considerations , 2004, European Radiology.

[59]  A Schiavone,et al.  Effects of material, coating, design and plaque composition on stent deployment inside a stenotic artery--finite element simulation. , 2014, Materials science & engineering. C, Materials for biological applications.

[60]  Jeffrey W Moses,et al.  Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. , 2003, The New England journal of medicine.

[61]  A. Göpferich,et al.  Mechanisms of polymer degradation and erosion. , 1996, Biomaterials.

[62]  Jun Ma,et al.  Sirolimus-eluting dextran and polyglutamic acid hybrid coatings on AZ31 for stent applications , 2015, Journal of biomaterials applications.

[63]  Yufeng Zheng,et al.  Effects of alloying elements (Mn, Co, Al, W, Sn, B, C and S) on biodegradability and in vitro biocompatibility of pure iron. , 2011, Acta biomaterialia.

[64]  F. Migliavacca,et al.  Influence of plaque calcifications on coronary stent fracture: a numerical fatigue life analysis including cardiac wall movement. , 2014, Journal of biomechanics.

[65]  N. Artzi,et al.  Sustained Efficacy and Arterial Drug Retention by a Fast Drug Eluting Cross-Linked Fatty Acid Coronary Stent Coating , 2015, Annals of Biomedical Engineering.

[66]  Weiqiang Wang,et al.  Analysis of the transient expansion behavior and design optimization of coronary stents by finite element method. , 2006, Journal of biomechanics.

[67]  Qing Li,et al.  Multiobjective robust optimization of coronary stents , 2016 .

[68]  R. Becker,et al.  Catheter thrombosis and percutaneous coronary intervention: fundamental perspectives on blood, artificial surfaces and antithrombotic drugs , 2009, Journal of Thrombosis and Thrombolysis.

[69]  Patrick W Serruys,et al.  Bioresorbable Scaffold: The Advent of a New Era in Percutaneous Coronary and Peripheral Revascularization? , 2011, Circulation.

[70]  O. C. Zienkiewicz,et al.  Computer procedures for finite element analysis , 2005 .

[71]  Antonio Colombo,et al.  Mechanism of Late In-Stent Restenosis After Implantation of a Paclitaxel Derivate–Eluting Polymer Stent System in Humans , 2002, Circulation.

[72]  Elazer R. Edelman,et al.  Constraining OCT with Knowledge of Device Design Enables High Accuracy Hemodynamic Assessment of Endovascular Implants , 2016, PloS one.

[73]  F. Etave,et al.  Mechanical properties of coronary stents determined by using finite element analysis. , 2001, Journal of biomechanics.

[74]  James E. Moore,et al.  Biomechanical Challenges to Polymeric Biodegradable Stents , 2015, Annals of Biomedical Engineering.

[75]  Lori Alquier,et al.  Drug Eluting Stents , 2012 .

[76]  C. M. Amatruda,et al.  Contribution of Mechanical and Fluid Stresses to the Magnitude of In-stent Restenosis at the Level of Individual Stent Struts , 2014 .

[77]  J. Dyet,et al.  Mechanical properties of metallic stents: How do these properties influence the choice of stent for specific lesions? , 2009, CardioVascular and Interventional Radiology.

[78]  Jeffrey W. Clark,et al.  A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma. , 2016, Biomaterials.

[79]  Elazer R Edelman,et al.  Intravascular drug release kinetics dictate arterial drug deposition, retention, and distribution. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[80]  Shijia Zhao,et al.  Effects of arterial strain and stress in the prediction of restenosis risk: Computer modeling of stent trials , 2012 .

[81]  R. Schwartz,et al.  Polymeric stents: modern alchemy or the future? , 1991, The Journal of invasive cardiology.

[82]  Elazer R. Edelman,et al.  Assessment of Material By-Product Fate from Bioresorbable Vascular Scaffolds , 2011, Annals of Biomedical Engineering.

[83]  Matthieu De Beule,et al.  Medical Stents : State of the Art and Future Directions A Computational Framework to Model Degradation of Biocorrodible Metal Stents Using an Implicit Finite Element Solver , 2015 .

[84]  Sean B. Leen,et al.  Experimental characterisation for micromechanical modelling of CoCr stent fatigue. , 2014, Biomaterials.

[85]  Takashi Saito,et al.  Effects of Stent Structure on Stent Flexibility Measurements , 2005, Annals of Biomedical Engineering.

[86]  Giancarlo Pennati,et al.  Fatigue behaviour of Nitinol peripheral stents: the role of plaque shape studied with computational structural analyses. , 2014, Medical engineering & physics.

[87]  Pascal Verdonck,et al.  A Novel Simulation Strategy for Stent Insertion and Deployment in Curved Coronary Bifurcations: Comparison of Three Drug-Eluting Stents , 2009, Annals of Biomedical Engineering.

[88]  Silvia Schievano,et al.  Computational studies of shape memory alloy behavior in biomedical applications. , 2005, Journal of biomechanical engineering.

[89]  G. Head,et al.  Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. , 2010, Journal of applied physiology.

[90]  Caoimhe A. Sweeney,et al.  A Review of Material Degradation Modelling for the Analysis and Design of Bioabsorbable Stents , 2015, Annals of Biomedical Engineering.

[91]  P. Serruys,et al.  Sirolimus-eluting stents remain superior to bare-metal stents at two years: medium-term results from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. , 2006, Journal of the American College of Cardiology.

[92]  Jaap Schijve,et al.  Fatigue of structures and materials , 2001 .

[93]  J J Wentzel,et al.  Relationship Between Neointimal Thickness and Shear Stress After Wallstent Implantation in Human Coronary Arteries , 2001, Circulation.

[94]  Claire Conway,et al.  Structural Mechanics Predictions Relating to Clinical Coronary Stent Fracture in a 5 Year Period in FDA MAUDE Database , 2015, Annals of Biomedical Engineering.

[95]  F. Atyabi,et al.  Preparation of gelatin microspheres containing lactic acid--effect of cross-linking on drug release. , 2005, Acta pharmaceutica.

[96]  C Dumoulin,et al.  Mechanical behaviour modelling of balloon-expandable stents. , 2000, Journal of biomechanics.

[97]  Odile Dechy-Cabaret,et al.  Controlled ring-opening polymerization of lactide and glycolide. , 2004, Chemical reviews.

[98]  Nicholas A Peppas,et al.  Recent advances in drug eluting stents. , 2013, International journal of pharmaceutics.

[99]  A. Tzafriri,et al.  Strut Position, Blood Flow, and Drug Deposition: Implications for Single and Overlapping Drug-Eluting Stents , 2005, Circulation.

[100]  Pavlos Vlachos,et al.  In Vitro, Time-Resolved PIV Comparison of the Effect of Stent Design on Wall Shear Stress , 2009, Annals of Biomedical Engineering.

[101]  A. Abizaid,et al.  New Drug-Eluting Stents: An Overview on Biodegradable and Polymer-Free Next-Generation Stent Systems , 2010, Circulation. Cardiovascular interventions.

[102]  R H Dean,et al.  Platelet-derived growth factor ligand and receptor expression in response to altered blood flow in vivo. , 1997, Circulation research.

[103]  O. C. Zienkiewicz,et al.  Chapter 15 – Computer Procedures for Finite Element Analysis , 2014 .

[104]  A Haverich,et al.  Left main coronary artery fistula exiting into the right atrium , 2003, Heart.

[105]  W. Cheong,et al.  Bioresorbable Vascular Scaffolds Versus Metallic Stents in Patients With Coronary Artery Disease: ABSORB China Trial. , 2015, Journal of the American College of Cardiology.

[106]  Claire Conway,et al.  A Computational Test-Bed to Assess Coronary Stent Implantation Mechanics Using a Population-Specific Approach , 2012 .

[107]  E. Edelman,et al.  Physiological Transport Forces Govern Drug Distribution for Stent-Based Delivery , 2001, Circulation.

[108]  Sanjay Pant,et al.  Geometry parameterization and multidisciplinary constrained optimization of coronary stents , 2011, Biomechanics and Modeling in Mechanobiology.

[109]  P. Prendergast,et al.  Simulation of In-stent Restenosis for the Design of Cardiovascular Stents , 2006 .

[110]  F. Auricchio,et al.  Stainless and shape memory alloy coronary stents: a computational study on the interaction with the vascular wall , 2004, Biomechanics and modeling in mechanobiology.

[111]  Salim Belouettar,et al.  On the numerical investigation of cardiovascular balloon-expandable stent using finite element method , 2013 .

[112]  Lee,et al.  Computational Fluid Dynamics Simulation on Biomedical Stent Design , 2011 .

[113]  E. Edelman,et al.  Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months. , 2000, Journal of the American College of Cardiology.

[114]  A. Tzafriri,et al.  Enhanced drug delivery capabilities from stents coated with absorbable polymer and crystalline drug. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[115]  Christopher Piorkowski,et al.  Prevalence and clinical impact of stent fractures after femoropopliteal stenting. , 2005, Journal of the American College of Cardiology.

[116]  P. Serruys,et al.  New concepts in the design of drug-eluting coronary stents , 2013, Nature Reviews Cardiology.

[117]  James E. Moore,et al.  Stented artery biomechanics and device design optimization , 2007, Medical & Biological Engineering & Computing.

[118]  L Petrini,et al.  Continuum damage model for bioresorbable magnesium alloy devices - Application to coronary stents. , 2011, Journal of the mechanical behavior of biomedical materials.

[119]  Caitríona Lally,et al.  The influence of plaque composition on underlying arterial wall stress during stent expansion: the case for lesion-specific stents. , 2009, Medical engineering & physics.

[120]  Patrick W. Serruys,et al.  Avances en el tratamiento mediante intervención coronaria percutánea: el stent del futuro , 2013 .

[121]  Chen Shanshan,et al.  Study of drug-eluting coating on metal coronary stent. , 2013, Materials Science and Engineering C: Materials for Biological Applications.

[122]  P. Serruys,et al.  A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. , 2002, The New England journal of medicine.

[123]  Francesco Migliavacca,et al.  Effects of different stent designs on local hemodynamics in stented arteries. , 2008, Journal of biomechanics.

[124]  Thomas Bewley,et al.  Optimization of Drug Delivery by Drug-Eluting Stents , 2015, PloS one.

[125]  Rupak K Banerjee,et al.  Developing pulsatile flow in a deployed coronary stent. , 2006, Journal of biomechanical engineering.

[126]  G. Mani,et al.  A stent for co-delivering paclitaxel and nitric oxide from abluminal and luminal surfaces: Preparation, surface characterization, and in vitro drug release studies , 2013 .

[127]  Caroline C. O'Brien,et al.  Vascular Response to Experimental Stent Malapposition and Under-Expansion , 2016, Annals of Biomedical Engineering.

[128]  Dimitrios I Fotiadis,et al.  Relationship of shear stress with in-stent restenosis: bare metal stenting and the effect of brachytherapy. , 2009, International journal of cardiology.

[129]  S. Hossainy,et al.  A mathematical model for predicting drug release from a biodurable drug-eluting stent coating. , 2008, Journal of biomedical materials research. Part A.

[130]  Chang-Soo Kim,et al.  FEA Study on the Stress Distributions in the Polymer Coatings of Cardiovascular Drug-Eluting Stent Medical Devices , 2014, Annals of Biomedical Engineering.

[131]  Fergal J Boyle,et al.  A full-range, multi-variable, CFD-based methodology to identify abnormal near-wall hemodynamics in a stented coronary artery. , 2010, Biorheology.

[132]  Salim Belouettar,et al.  Numerical investigations of the structural behavior of a balloon expandable stent design using finite element method , 2013 .

[133]  Francesco Migliavacca,et al.  Modeling Stented Coronary Arteries: Where We are, Where to Go , 2012, Annals of Biomedical Engineering.

[134]  E. Sacco,et al.  Finite-element Analysis of a Stenotic Artery Revascularization Through a Stent Insertion , 2001 .

[135]  David Martin,et al.  Computational structural modelling of coronary stent deployment: a review , 2011, Computer methods in biomechanics and biomedical engineering.

[136]  Kuang-Huei Lee,et al.  Computational modeling of effects of intravascular stent design on key mechanical and hemodynamic behavior , 2012, Comput. Aided Des..

[137]  Raimund Erbel,et al.  Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial , 2013, The Lancet.

[138]  Dimitrios I Fotiadis,et al.  The effect of shear stress on neointimal response following sirolimus- and paclitaxel-eluting stent implantation compared with bare-metal stents in humans. , 2010, JACC. Cardiovascular interventions.

[139]  Michail I. Papafaklis,et al.  Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden. , 2007, Journal of the American College of Cardiology.

[140]  Brad A James,et al.  Fatigue-life assessment and validation techniques for metallic vascular implants. , 2010, Biomaterials.

[141]  T. Simard,et al.  The evolution of coronary stents: a brief review. , 2014, The Canadian journal of cardiology.

[142]  Yanjun Zeng,et al.  Fatigue life analysis and experimental verification of coronary stent , 2010, Heart and Vessels.

[143]  Ousa,et al.  A RANDOMIZED COMPARISON OF A SIROLIMUS-ELUTING STENT WITH A STANDARD STENT FOR CORONARY REVASCULARIZATION , 2002 .

[144]  Jean-Marc Chomaz,et al.  Modeling the transport of drugs eluted from stents: physical phenomena driving drug distribution in the arterial wall , 2014, Biomechanics and Modeling in Mechanobiology.

[145]  E. Edelman,et al.  Arterial paclitaxel distribution and deposition. , 2000, Circulation research.

[146]  D. Mantovani,et al.  Degradation Behaviour of Metallic Biomaterials for Degradable Stents , 2006 .

[147]  P E McHugh,et al.  A corrosion model for bioabsorbable metallic stents. , 2011, Acta biomaterialia.

[148]  Deepak L. Bhatt,et al.  Antiplatelet therapy in coronary heart disease prevention. , 2011, Cardiology clinics.

[149]  Galo Maldonado,et al.  1-year results of the hydroxyapatite polymer-free sirolimus-eluting stent for the treatment of single de novo coronary lesions: the VESTASYNC I trial. , 2009, JACC. Cardiovascular interventions.

[150]  Siegfried Schmauder,et al.  Comput. Mater. Sci. , 1998 .

[151]  Huajiang Ouyang,et al.  Shape optimization of coronary artery stent based on a parametric model , 2009 .

[152]  Nandini Duraiswamy,et al.  Comparison of near-wall hemodynamic parameters in stented artery models. , 2009, Journal of biomechanical engineering.

[153]  Diego Mantovani,et al.  Biodegradable Metals for Cardiovascular Stent Application: Interests and New Opportunities , 2011, International journal of molecular sciences.

[154]  Saibal Kar,et al.  Polymer-Free Biolimus A9–Coated Stent Demonstrates More Sustained Intimal Inhibition, Improved Healing, and Reduced Inflammation Compared With a Polymer-Coated Sirolimus-Eluting Cypher Stent in a Porcine Model , 2010, Circulation. Cardiovascular interventions.